WLF Appeal Could Be Heard By Spring Under FDA Expedited Appeal Request
This article was originally published in The Gray Sheet
Executive Summary
The Washington Legal Foundation will challenge FDA's request for an expedited appeal to D.C. District Court Judge Royce Lamberth's July 28 ruling invalidating the off-label dissemination provisions of the FDA Modernization Act, WLF General Counsel Richard Samp told a Food & Drug Law Institute conference Sept. 13 in Bethesda, Maryland.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.